Copy into your RSS Reader
Copy into your Podcast App
The active ingredient in Propecia, a baldness remedy approved by the Food and Drug Administration in 1997, is showing new promise as a way to prevent some prostate cancers.
August 14, 2013 Doctors have debated for years whether a drug that curbed the growth of some prostate cancers caused more serious ones to grow faster. Now, a long-term study calms those fears and raises the possibility that a cheap, generic pill could be used reduce prostate cancer risk.
<iframe src="http://www.npr.org/player/embed/212046489/212052975" width="100%" height="290" frameborder="0" scrolling="no">
Sally O'Neill decided to have a double mastectomy rather than "do a wait-and-see."
August 5, 2013 The question of how to treat ductal carcinoma in situ is roiling the medical profession, and making for tough choices for women. The condition may never become invasive cancer. But some women choose to have mastectomies rather than live with uncertainty.
<iframe src="http://www.npr.org/player/embed/208239545/209097968" width="100%" height="290" frameborder="0" scrolling="no">
At least they're talking.
July 11, 2013 Doctors are supposed to engage patients in shared decision-making over complex choices like whether or not to get tested for prostate cancer. But most doctors don't do that, a survey finds. And efforts to train doctors to do a better job haven't been all that successful.
A billboard advertising robotic surgery hangs outside Boston's Fenway Park in 2009. Hospitals and doctors have heavily promoted robotic surgery.
June 26, 2013 Men with low-grade prostate cancer are choosing robotic surgery and other expensive treatments, even though they probably don't need treatment at all, a study says. Less testing and waiting before deciding to treat would reduce harmful side effects in many cases.
June 10, 2013 Replacing some dietary carbohydrates with vegetable fats may help keep prostate cancer from spreading. That's the word from a study of more than 4,500 men that looked at the effects of dietary changes after their initial diagnosis.
Terry Dyroff, of Silver Spring, Md., had a PSA blood test that led to a prostate biopsy. The biopsy found no cancer but did give him a life-threatening infection.
Jose Luis Magana/AP
May 3, 2013 The American Urological Association released new guidelines that, if they're heeded, would dramatically reduce the ranks of men who would be candidates for PSA testing. The prostate-specific antigen test can catch cancer early, but it frequently gives false alarms.
When is the right time to check the PSA box?
February 5, 2013 Testing for prostate cancer may not get any less confusing anytime soon. But researchers say the much-maligned PSA screening test is worthwhile if it's used for the right men at the right time.
Radiation therapist Jean Etienne holds a range compensator, which shapes the depth to which the proton beam enters a patient's body to target a tumor.
October 29, 2012 Proton therapy can be targeted much more precisely than regular radiation. The hope is that it translates into far fewer side effects, such as impotence and incontinence. But it also costs twice as much as regular radiation. And there's no proof it's more effective — it could potentially be worse, say some radiation experts.
<iframe src="http://www.npr.org/player/embed/163635298/163845729" width="100%" height="290" frameborder="0" scrolling="no">
Dr. Karen Lindsfor, a radiologist at the University of California, Davis, Medical Center, reads a mammogram in Sacramento, Calif.
September 6, 2012 There are conflicting guidelines on when women should get mammograms and mounting questions on when the PSA blood test for prostate cancer is worthwhile. We asked how people are sorting things out.
Surgery for prostate cancer shouldn't be an automatic choice, a new study says.
July 18, 2012 A study of more than 700 men with prostate cancer found no difference in rates of death among men who had their prostates surgically removed compared to those who didn't. The findings suggest that men with low-risk cancers could forgo surgery.
May 28, 2012 A federal task force's recommendations against routine blood tests for prostate cancer raises big questions about how to interpret medical evidence and what role expert panels should play in how doctors practice. But those questions aren't easy to answer.
<iframe src="http://www.npr.org/player/embed/153879847/153883324" width="100%" height="290" frameborder="0" scrolling="no">
May 24, 2012 Johns Hopkins researcher round that nearly three-quarters of primary care doctors they surveyed said their patients expected regular PSA screening to continue. The findings suggest there will be
May 23, 2012 The U.S. Preventive Services Task Force said the harms, such as false alarms and unnecessary surgeries that leave some men impotent and incontinent, outweigh the benefits of routine PSA blood testing for prostate cancer. But it's far from clear that doctors and their patients will heed the advice.
Terry Dyroff, at home in Silver Spring, Md., got a PSA blood test that led to a prostate biopsy. The biopsy found no cancer, but it gave him a life-threatening infection.
Jose Luis Magana/AP
May 21, 2012 The U.S. Preventive Services Task Force says the testing doesn't save enough lives to justify the risk of unnecessary surgery and radiation. But one testing supporter says, "If all PSA screening were to stop, there would be thousands of men who would unnecessarily suffer and die from prostate cancer."
<iframe src="http://www.npr.org/player/embed/153234671/153224081" width="100%" height="290" frameborder="0" scrolling="no">
April 18, 2012 Billionaire Warren Buffett was tested for prostate cancer at an age when most men are not. The evidence suggests that in most cases the harms of treatment of prostate cancer in elderly men outweigh its benefits.
The problem of breast cancer overdiagnosis with mammograms is similar to the dilemma faced by men diagnosed with prostate cancer because of a PSA test.
April 3, 2012 Norwegian scientists say as many as 1 in every 4 cases of breast cancer doesn't need to be found because it would never have caused symptoms or death. They also question a fundamental justification of mammography: that it finds more cancers when they're early and more curable.
March 12, 2012 Researchers found a 15 percent lower risk of prostate cancer among circumcised men than those who hadn't been circumcised. But the study doesn't prove that circumcision would work, though there're some reason to think it might.
December 7, 2011 An panel of experts convened by the National Institutes of Health suggests doctors should rethink their approach to treating prostate cancers. One of the recommendations is most low-risk prostate tumors shouldn't be labeled as cancer in the first place.
October 26, 2011 Confused about the fuss over PSA screening for prostate cancer? A commentary in the New England Journal of medicine says there's a middle ground between business-as-usual and throwing PSA tests out altogether.
Former House Speaker Newt Gingrich makes a point during the presidential debate sponsored at Dartmouth College in Hanover, New Hampshire, Tuesday night.
October 12, 2011 Newt Gingrich invoked Dr. Andrew von Eschenbach, former head of the National Cancer Institute, in criticizing proposed changes in prostate cancer screening. A close watcher of von Eschenbach at NCI questioned whether he is the right person to lean on.
October 12, 2011 In the first hour of Talk of the Nation, the political junkie, and screening and treating prostate cancer. In the second hour, the life of Mary Boleyn, and the art and science of creating a successful brand name.
October 11, 2011 The largest study yet to test whether daily vitamin E supplements could reduce the risk of prostate cancer finds they may have the opposite effect, raising the chances of illness by 17 percent.
October 7, 2011 Sometimes it is better not to know, than to know, at least according to a panel of medical experts. But is this a medical finding?
Chicago attorney Tom Hayward suffered a raging infection after a prostate biopsy. He had to be hospitalized, but has since recovered.
October 7, 2011 Routine testing of men's blood to detect prostate cancer is unwarranted, and causes more harm than good, according to findings of the U.S. Preventive Services Task Force. The panel of experts sets the agenda for doctors and, increasingly, insurance payments.
<iframe src="http://www.npr.org/player/embed/141148384/141162175" width="100%" height="290" frameborder="0" scrolling="no">
NPR thanks our sponsors
Become an NPR sponsor